New York
Broadfin Capital is a global equity healthcare manager founded in 2005 achieving its returns through the consistent application of a value-oriented investment strategy based on deep, fundamental research. Drawing on its partners’ research and investment experience in the medical technology, pharmaceutical, and biotechnology sectors, the Broadfin Healthcare Fund’s exposure is predominantly in medical technology and pharmaceutical/ specialty pharma/ biotech stocks. The fund has a global focus with bias towards the US and generally has 70 to 100 positions, moderately concentrated, with approximately 50% of capital invested in the top 10 names. [endif]
Fund Details
Fund News